✦ LIBER ✦

Comparison of performance of various tumour response criteria in assessment of regorafenib activity in advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib

✍ Scribed by Shinagare, Atul B.; Jagannathan, Jyothi P.; Kurra, Vikram; Urban, Trinity; Manola, Judith; Choy, Edwin; Demetri, George D.; George, Suzanne; Ramaiya, Nikhil H.

Book ID: 125457534
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 409 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2013.11.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regorafenib: A Guide to Its Use in Advan

Regorafenib: A Guide to Its Use in Advanced Gastrointestinal Stromal Tumor (GIST) After Failure of Imatinib and Sunitinib

✍ Lyseng-Williamson, Katherine A. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 253 KB

Clinical evaluation of continuous daily

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

✍ S. George; J.Y. Blay; P.G. Casali; A. Le Cesne; P. Stephenson; S.E. DePrimo; C.S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 523 KB

Efficacy and safety of sunitinib in pati

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

✍ George D Demetri; Allan T van Oosterom; Christopher R Garrett; Martin E Blackste 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 201 KB

Efficacy and safety of regorafenib for a

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

✍ Demetri, George D; Reichardt, Peter; Kang, Yoon-Koo; Blay, Jean-Yves; Rutkowski, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 348 KB

Nilotinib in the treatment of advanced g

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib

✍ M. Montemurro; P. Schöffski; P. Reichardt; H. Gelderblom; J. Schütte; J.T. Hartm 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Phase II study of dovitinib in patients

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib

✍ Kang, Y-K; Yoo, C; Ryoo, B-Y; Lee, J J; Tan, E; Park, I; Park, J H; Choi, Y J; J 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 682 KB